ESG
Douglas releases its 2025 Environmental, Social and Governance Report
December 12, 2025
|
December 12, 2025
|From reducing our carbon footprint to ensuring ethical supply chains, environmental, social, and governance (ESG) considerations are no longer just good practice – they're critical for reputation, and our long-term ability to deliver life-changing medicines.
At Douglas, we understand our profound responsibility to contribute to a greener, more ethical pharmaceutical supply chain. As a leading supplier of pharmaceuticals to countries around the globe, our dedication to sustainability is a core part of who we are.
It's not just about compliance; it's about leading with purpose. Our commitment is clearly evidenced by our internationally recognised sustainability certifications, which provide tangible proof of our efforts and offer our global partners and patients confidence in our shared ESG objectives.
As a pharmaceutical manufacturer and supplier, Douglas is uniquely positioned to drive sustainability across the entire drug product lifecycle. By integrating sustainable practices into our core operations, we aim to:
We focus on optimising our manufacturing processes, enhancing energy efficiency, reducing waste, and responsibly managing resources.
We have a supplier code of conduct that requires fair labour and robust supply chain management.
Our commitment to sustainability helps us meet evolving global regulatory requirements and benefits our partners, patients, and stakeholders worldwide. Independent evaluations are important in validating our progress.
For pharmaceutical companies and healthcare providers around the world, partnering with Douglas means engaging with a supplier who possesses recognised sustainability certifications like EcoVadis Bronze and Toitū Carbonzero. This offers significant advantages:
De-risked supply chain: Our certifications provide assurance of our adherence to high environmental and ethical standards, reducing supply chain risks.
Enhanced ESG reporting: Working with us contributes positively to your own Scope 3 emissions reporting and overall ESG performance metrics.
Shared values: Aligning with a pharmaceutical supplier committed to sustainability reinforces your brand's responsible image in the market.
Reliable and responsible supply: Benefit from a partner who not only delivers essential medicines but does so with a proven commitment to planetary and social well-being.
At Douglas, we understand that building a sustainable future for healthcare requires collective effort. We are committed to leading by example in our global operations, ensuring that together, we can deliver life-changing medicines with a positive impact on the planet and its people.